NAKAW 最新10-Q变化
将 NAKAW 最新的定期申报(10-K/10-Q)与上一份同类型申报逐章节对比:每个章节新增/删除的段落数与原文摘录。全部为确定性文本对比——无相似度评分、无方向判断、非投资建议。
对比:10-Q · 2026-08-13 与上一份 10-Q · 2026-05-13
| 章节 | 结果 | 新增 | 删除 | 微调 | 未变 |
|---|---|---|---|---|---|
| 管理层讨论与分析 | 文字有新增/删除 | +76 | −42 | ~12 | 14 |
| 市场风险(第3项) | 无段落级文字变化 | 0 | 0 | 0 | 1 |
| 控制与程序 | 文字有新增/删除 | 0 | 0 | ~2 | 0 |
| 法律诉讼 | 文字有新增/删除 | 0 | −1 | ~1 | 1 |
| 风险因素 | 部分风险因素更新 | +7 | 0 | ~1 | 0 |
计数单位为段落;"新增/删除"指相对上一份文件新增/删除的文字,不含方向或好坏判断。
未列出(无法可靠提取或缺失):其他信息
代表性摘录
每个章节最多 5 条、每条约 300 字符的原文摘录,直接来自两份 SEC 文件。
管理层讨论与分析
相对上期新增的文字 · 来源:10-Q · 2026-08-13
● Disruption in the economic and financial conditions primarily from the impact of past terrorist attacks, threats of future attacks, police, and military activities overseas and other disruptive worldwide political and economic events and environmental weather conditions;
References to “Nakamoto,” “the Company,” “we,” or “us” in this section are intended to mean the business and operations of Nakamoto Inc. formerly known as KindlyMD, Inc., together with its subsidiaries.
In March 2026, we announced our intention to exit our legacy healthcare business, and we closed our last healthcare clinic on June 19, 2026. Results of our legacy healthcare are now reported as discontinued operations.
The transformation from a healthcare company to a Bitcoin operating company affects the comparison of our results in 2026 to 2025. Throughout the first half of 2025, we operated solely as a healthcare company. We did not begin our transformation into a Bitcoin operating company until the Nakamoto Me…
Media & Information Services Included Included from February 20
相对上期删除的文字 · 来源:10-Q · 2026-05-13
● The general volatility of the capital markets and the establishment of a market for our shares;
● Disruption in the economic and financial conditions primarily from the impact of past terrorist attacks in the United States, threats of future attacks, police, and military activities overseas and other disruptive worldwide political and economic events and environmental weather conditions;
The transformation from a healthcare company to a Bitcoin operating company affects the comparison of our results in 2026 to 2025. The table below shows the segments included in each period:
The following tables set forth our summary consolidated results of operations in dollars for the periods presented. The period-to-period comparisons of our historical results are not necessarily indicative of the results that may be expected in the future. The results of operations for the three mon…
Change in fair value of call option - related party (107,744) -
法律诉讼
相对上期删除的文字 · 来源:10-Q · 2026-05-13
For the matters we disclose that do not include an estimate of the amount of loss or range of losses, such an estimate is not possible or is immaterial, and we may be unable to estimate the possible loss or range of losses that could potentially result from the application of non-monetary remedies. …
风险因素
相对上期新增的文字 · 来源:10-Q · 2026-08-13
Our Common Stock repurchase program may not enhance stockholder value, and any repurchases will diminish our cash reserves.
On June 10, 2026, our Board approved the adoption of the 2026 Repurchase Program, providing for the repurchase of up to $25.0 million of our outstanding shares of Common Stock. The 2026 Repurchase Program expires on December 31, 2026, does not obligate us to repurchase any dollar amount or number of…
If we fail to maintain compliance with Nasdaq’s continued listing requirements, our Common Stock could be delisted.
Our Common Stock must satisfy Nasdaq’s continued listing requirements, including the requirement that its closing bid price be at least $1.00 per share. We are currently in compliance with Nasdaq’s other continued listing requirements, but there is no assurance we will remain so in the future. On De…
If our Common Stock again fails to satisfy the minimum bid price requirement at a time when the May 22, 2026 reverse stock split falls within the one-year period preceding that failure, we will not be eligible for any compliance period otherwise available under Nasdaq’s rules, and under Nasdaq Listi…
如何读 10-Q 的风险因素(第 1A 项)
10-Q 的风险因素章节有三种常见形态,本页按其一分类展示:
- 指向(pointer) — 公司仅声明"无重大变化"并指向年度 10-K 的完整风险因素;本季没有自己的风险文本可对比。
- 部分更新(partial) — 公司写明"除下述外无重大变化",只更新部分风险;摘录展示的正是本季新增的内容。
- 全文重述(restated) — 本季重新给出完整风险因素。若上一季只是"指向",则无法逐段对比,本页会将其标为"本季全文重述"。
这只是对文件结构的客观描述,不构成对风险高低的判断。
数据来自 SEC EDGAR 两份申报文件的文本级对比 · 确定性计算(无 AI 生成内容)· 仅供参考 · 非投资建议